Spectrum Pharmaceuticals

.

FDA OK’s Spectrum Cancer Drug for Wider Use

Spectrum Pharmaceuticals

An Irvine drug maker, Spectrum Pharmaceuticals Inc., has said that it got regulatory approval for an expanded use of a cancer drug.

Spectrum said that the FDA approved Zevalin as an early treatment for a blood cancer, in patients with non-Hodgkin's lymphoma. The drug was used previously on patients whose tumors did not respond to other treatments.

Spectrum Pharmaceuticals inks 50:50 JV pact with Cell Therapeutics

Spectrum Pharmaceuticals inks 50:50 JV pact with Cell Therapeutics Spectrum Pharmaceuticals and Cell Therapeutics have entered into an agreement to form a 50:50 owned joint venture, RIT Oncology, to commercialize and develop Zevalin in the United States.

Latest News

Exxon CEO Rebuffs Criticism of Not Doing Enough to Cut Carbon Emissions
McDonald’s Toasting Buns for Longer to get Better Taste
SWIFT says, Yuan is presently the Most-Used Currency in Asia for Payments to Chi
U.S. Dollar gets a Lift Strengthening Hopes of Raise in Interest Rate
Hackers Steal Tax Information of 100,000 American Taxpayers from IRS site
Charter Communications is Acquiring Time Warner Cable for about $56 Billion
Greece’s Interior Minister Says Greece will not be Able to Repay Debt Next Month
Nikos Voutsis, Greece’s Interior Minister
Rig Count in U.S Slows, Oil Trades Close to $60
Third Annual ‘March against Monsanto’ held on Saturday
In Response to Tuesday’s Oil Spill, Governor Jerry Brown
Ruptured Oil Pipeline Leads to 21,000 gallons of Oil Flowing into California Coa
Syndicate content